Clinical Trials on Bladder Cancer in Mexico

Total 1285 results

AstraZeneca

Withdrawn

CMAB vs IMAB in Metastatic Prostate Cancer

Metastatic Prostate Cancer

Mexico
Instituto Nacional de Cancerologia de Mexico

Recruiting

Glutamine Plus L. Reuteri Prevents TKI Therapy-diarrhea in Patients With NSCLC

Non-Small Cell Lung Cancer With EGFR Mutation

Mexico
Astellas Pharma Europe B.V.

Completed

Open-label Phase 3 Study With Mirabegron in Children From 3 to Less Than 18 Years of Age With Neurogenic Detrusor Overactivity (Crocodile)

Neurogenic Detrusor Overactivity

Belgium, Croatia, Turkey, Australia, Denmark, Israel, Jordan, Korea, Republic of, Latvia, Lithuania, Malaysia, Mexico, Norway, Philippines, Poland, Romania, Serbia, Slovakia, Taiwan
University of New Mexico

Recruiting

Mindfulness and Yoga for Pain With Interstitial Cystitis Evaluation (MYPAICE)

Interstitial Cystitis

United States
Instituto Nacional de Cancerologia de Mexico

Completed

Effect of Mirtazapine Versus Placebo in Patients With Non-small Cell Lung Cancer and Anorexia

Anorexia | Non-small Cell Lung Cancer

Mexico
Merck Sharp & Dohme LLC

Active, not recruiting

Perioperative Pembrolizumab (MK-3475) Plus Neoadjuvant Chemotherapy Versus Perioperative Placebo Plus Neoadjuvant Chemotherapy for Cisplatin-eligible Muscle-invasive Bladder Cancer (MIBC) (MK-3475-866/KEYNOTE-866) (KEYNOTE-866)

Bladder Cancer

Canada, United States, Australia, Belgium, Denmark, France, Germany, Hungary, Ireland, Israel, Italy, Japan, Korea, Republic of, Mexico, Poland, Russian Federation, Spain, Sweden, Thailand, Turkey, Ukraine, United Kingdom
Astellas Pharma Europe B.V.

Completed

A Study to Investigate How Safe and Effective Solifenacin Solution is in Treating Children/Adolescents With Symptoms of Overactive Bladder (OAB) Who Completed Study 905-CL-076 (LEOPARD)

Urinary Bladder, Overactive

Belgium, United States, Brazil, Canada, Denmark, Former Serbia and Montenegro, Korea, Republic of, Mexico, Norway, Philippines, Poland, South Africa, Sweden, Turkey, Ukraine, United Kingdom
Instituto Nacional de Cancerologia de Mexico
AstraZeneca

Completed

Neoadjuvant Hormonal Treatment of Postmenopausal Women Who Have Operable Breast Cancer

Breast Cancer

Mexico
Williams Cancer Foundation
Syncromune, Inc.

Active, not recruiting

Phase 1 Trial of SYNC-T - Immunotherapy for Advanced/Metastatic Castration-Resistant Prostate Cancer

Metastatic Castration-resistant Prostate Cancer

Mexico
National Institute of Cancerología
Instituto Nacional de Enfermedades Respiratorias

Completed

K-RAS Oncogene Mutation in Patients With Advanced Non-Small Cell Lung Cancer Associated With Exposure to Wood Smoke and Tobacco Smoking: Therapeutic Implications (007/055/OMI)

Non-Small Cell Lung Cancer

Mexico
Astellas Pharma Europe B.V.

Completed

A Study to Investigate How Effective and Safe Solifenacin Succinate Suspension is in Treating Children/Adolescents Aged 5 to Less Than 18 Years With Symptoms of Overactive Bladder (OAB) Compared to a Non-active Drug (LION)

Urinary Bladder, Overactive

Belgium, United States, Brazil, Canada, Denmark, Former Serbia and Montenegro, Korea, Republic of, Mexico, Norway, Philippines, Poland, South Africa, Sweden, Turkey, Ukraine, United Kingdom
Instituto Nacional de Ciencias Medicas y Nutricion...

Completed

Germline Mutations Associated With Hereditary Pancreatic Cancer in Unselected Patients With Pancreatic Cancer in Mexico

Pancreatic Cancer | Pancreatic Adenocarcinoma

Mexico
Duramed Research

Completed

A Safety Extension Study of DR-OXY-301

Overactive Bladder

United States
National Institute of Cancerología

Unknown

Effect of All-trans Retinoic Acid With Chemotherapy Based on Paclitaxel and Cisplatin As First-line Treatment of Patients With Advanced Non-small Cell Lung Cancer and Expression of RAR-alfa and RAR-beta as Response Biomarker

Non Small Cell Lung Cancer

Mexico
Astellas Pharma Europe B.V.

Completed

A Multinational Study Comparing the Long-term Efficacy and Safety of Two Medicines, Solifenacin Succinate and Mirabegron Taken Together, or Separately, in Subjects With Symptoms of Overactive Bladder (SYNERGY II)

Overactive Bladder | Urgency Incontinence | Urinary Bladder Overactive | Urinary Bladder Diseases\Urologic Diseases

Belgium, Russian Federation, Korea, Republic of, United States, Germany, Spain, Australia, Bulgaria, Canada, Czechia, Denmark, Estonia, Finland, Hungary, Italy, Latvia, Lithuania, Malaysia, Mexico, Netherlands, New Zealand, Norway, ... and more
Instituto Nacional de Cancerologia de Mexico

Recruiting

Nitroglycerin Plus Radiotherapy Versus Conventional Radiotherapy in Patients With Lung Cancer.

Non-small Cell Lung Cancer | Brain Metastases | EGFR Gene Mutation

Mexico
National Institute of Cancerología
Sabinsa Corporation

Recruiting

Curcumin Supplementation in Cervical Cancer

Locally Advanced Cervical Cancer

Mexico
National Institute of Cancerología
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran; Yakult... and other collaborators

Completed

Use of a Fermented Dairy Beverage in Cervical Cancer Patients Undergoing Concurrent Chemoradiation Therapy

Cervical Cancer, Stage IIB

Mexico
New Mexico Cancer Care Alliance
Ohio State University Comprehensive Cancer Center; H. Lee Moffitt Cancer Center...

Recruiting

Total Cancer Care Protocol: A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer (TCCP)

Cancer | Cancer Risk

United States
Instituto Nacional de Ciencias Medicas y Nutricion...
University of Sao Paulo; Ethicon Endo-Surgery

Unknown

Comparative Analysis Between Bipolar Device and Conventional Tie & Suture Technique in Thyroidectomy

Papillary Thyroid Cancer | Thyroid Goiter

Mexico, Brazil
Instituto Nacional de Cancerologia de Mexico

Completed

Tetracycline as a Prophylaxis for Rash in Patients With NSCLC Receiving Treatment With BIBW2992 (Afatinib)

Lung Cancer | Skin Rash

Mexico
National Institute of Cancerología
Psicofarma S.A. de C.V.

Unknown

Hydralazine Valproate for Cervical Cancer

Metastatic Cervical Cancer

Mexico
Hospital General de México Dr. Eduardo Liceaga

Unknown

Clinical Trial Comparing the Self-test for Cervicovaginal Sample Versus Samples From Service Provider (Xyto-Ro) (Xyto-Ro)

HPV DNA | Human Papillomavirus (HPV)-Related Cervical Cancer

Mexico
University of California, San Francisco
Pfizer

Completed

Bringing Simple Urge Incontinence Diagnosis & Treatment to Providers (BRIDGES) (BRIDGES)

Overactive Bladder | Urge Urinary Incontinence

United States
National Institute of Cancerología

Completed

A Monoclonal Antibody, Nimotuzumab, as Treatment for Recurrent or Metastatic Cervical Cancer

Uterine Cervical Cancer

Mexico
Instituto Nacional de Cancerologia de Mexico

Completed

Treatment With BIBW 2992, Irreversible Inhibitor of EGFR and HER-2 in Non-small Cell Lung Cancer (NSCLC)

Non-Small Cell Lung Cancer | EGFR | HER-2

Mexico
Boehringer Ingelheim

Completed

Study to Evaluate the Efficacy and Safety of Tamsulosin in Children With Neurogenic Bladder

Bladder, Neurogenic

Belgium, Spain, United States, India, South Africa, Philippines, Italy, Korea, Republic of, Russian Federation, Germany, Brazil, Mexico, Ukraine
National Institute of Cancerología

Unknown

Gene-expression Profiles in CNS-metastatic Non-small Cell Lung Cancer

Lung Cancer | Metastasis | Brain Disease

Mexico
Coordinación de Investigación en Salud, Mexico

Recruiting

Hypofractionated Radiation Therapy vs Standard Treatment in Breast Cancer.

Stage 0 Breast Cancer | Stage I Breast Cancer | Invasive Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Ductal Breast Carcinoma in Situ | Early-stage Breast Cancer

Mexico
Astellas Pharma Europe B.V.

Completed

This Was a Multinational Study Comparing the Efficacy and Safety of Two Medicines , Solifenacin Succinate and Mirabegron Taken Together, or Separately, or a Mock Treatment (Placebo) in Subjects With Symptoms of Overactive Bladder (SYNERGY)

Overactive Bladder | Urgency Incontinence | Urinary Bladder Overactive | Urinary Bladder Diseases\Urologic Diseases

United States, Argentina, Australia, Belgium, Bulgaria, Canada, China, Colombia, Czechia, Denmark, Estonia, Finland, France, Germany, Greece, Hong Kong, Hungary, Italy, Korea, Republic of, Latvia, Lithuania, Malaysia, Mexico, Netherlands and more
Instituto Nacional de Cancerologia de Mexico

Completed

Clinicopathological Features of NSCLC Patients Associated With the Chromosome 2p (EML4-ALK) (ALK)

Non Small-cell Lung Cancer

Mexico
Instituto Nacional de Cancerologia, Columbia

Unknown

Trastuzumab or Observation After Combination Chemotherapy and Trastuzumab in Treating Patients Undergoing Surgery for Stage II or Stage III Breast Cancer

Breast Cancer

Mexico
Instituto Nacional de Cancerologia de Mexico

Completed

Ketamine or Placebo in Patients With Major Depression and Advanced Cancer (KODIAC)

Major Depressive Disorder | Advanced Cancer

Mexico
Instituto Nacional de Cancerologia de Mexico

Unknown

Nabilone Effect on the Attenuation of Anorexia, Nutritional Status and Quality of Life in Lung Cancer Patients

Anorexia | Non-Small Cell Lung Cancer | Cachexia | Weight Lose

Mexico
Instituto Nacional de Ciencias Medicas y Nutricion...
Conquer Cancer Foundation

Recruiting

Validation of Advanced Colorectal Neoplasm Risk Categories in a Prospective Cohort in Mexico (COLOFIT)

Colorectal Cancer Screening

Mexico
Astellas Scientific & Medical Affairs, Inc.

Completed

A Prospective, Observational, Multicenter Study of Patients Following Initiation of a New Course of Treatment for Overactive Bladder (OAB) (PERSPECTIVE)

Urologic Diseases | Overactive Bladder | Urinary Bladder Diseases | Urinary Bladder Overactive

United States, Canada
Instituto Nacional de Cancerologia de Mexico

Unknown

Evaluation of PD1 / PDL1 Expression on Blood Cells & Tumor Tissue, Their Role as a Prognostic Target in NSCLC Patients

Non-Small Cell Lung Cancer

Mexico
Instituto Nacional de Cancerologia de Mexico

Active, not recruiting

Oscillating Positive Expiratory Pressure Therapy for Patients With Thoracic Neoplasms Undergoing Chest Surgery (AEROBIKA)

Lung Cancer | Mediastinal Tumor | Pleural Tumor

Mexico
Boehringer Ingelheim

Completed

PK/PD, Long-term Safety and Efficacy of Tamsulosin Treatment in Children With Neurogenic Bladder

Bladder, Neurogenic

Belgium, Spain, United States, South Africa, Philippines, Italy, Korea, Republic of, Russian Federation, Germany, India, Brazil, Canada, Mexico, Ukraine
University of New Mexico

Completed

Cancer Center Trials: Reasons for Low Accrual Rates at One Academic Institution Vs. The Community Setting

Cancer

United States
Laboratorios Liomont
Servicios Especializados en Ensayos Clínicos, S.C.

Recruiting

Safety of Effivia®, a Bevacizumab Biosimilar

Metastatic Colorectal Cancer | Metastatic Cervical Cancer | Non Squamous Non Small Cell Lung Cancer

Mexico
University of New Mexico
Hyundai Hope On Wheels

Withdrawn

A Brief Parental Intervention on Learning and Education in Childhood Cancer

Cancer

United States
New Mexico Cancer Care Alliance
The Feminist Majority Foundation

Terminated

Compassionate Use of Mifepristone in Brain/Nervous System and Other Cancers

Cancer

United States
National Institute of Cancerología
Abbott

Unknown

Effect on the Nutritional and Inflammatory Status of Docosahexaenoic Acid (DHA) and Eicosapentaenoic Acid (EPA)- Containing Supplement in Patients With Advanced Lung Cancer

Lung Cancer

Mexico
University of New Mexico

Terminated

Adverse Childhood Experiences in Urogynecologic Patients (ACE-UP)

Urinary Incontinence | Pelvic Floor Disorders | Interstitial Cystitis

United States
University of New Mexico
National Cancer Institute (NCI)

Completed

Remote Assessment of Physical Function

Cancer Survivors

United States
University of New Mexico
New Mexico State University; University of New Mexico Cancer Center

Completed

Southwest Harvest for Health Vegetable Gardening Intervention

Cancer Survivor

United States
Nektar Therapeutics
Bristol-Myers Squibb

Completed

A Single-Arm Study of Bempegaldesleukin (NKTR-214) Plus Nivolumab in Cisplatin Ineligible Patients Who Have Locally Advanced or Metastatic Urothelial Cancer (PIVOT-10)

Neoplasm Metastasis | Urinary Bladder Neoplasm

United States, Spain, United Kingdom, Belgium, Canada, Australia, France, Italy, Greece, Germany, Portugal, Argentina, Israel, Russian Federation, Turkey, Mexico, Finland, Netherlands
Astellas Pharma Global Development, Inc.

Completed

Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Older Adult Subjects With Overactive Bladder (OAB) (PILLAR)

Overactive Bladder (OAB)

United States, Canada
Instituto Mexicano del Seguro Social

Completed

Pain Comparison Whit Visual Analog Scale (EVA) Between Four Analgesic Methods During Trans Rectal Prostatic Biopsy

Cancer of Prostate

Mexico

Clinical Trials on Bladder Cancer in Mexico

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United Kingdom

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations